• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MannKind Corp

+ Add to Watchlist

NNF1:GR

4.658 EUR 0.062 1.35%

As of 07:04:33 ET on 04/17/2014.

Snapshot for MannKind Corp (NNF1)

Open: 4.571 Day's Range: 4.566 - 4.658 Volume: 335
Previous Close: 4.596 52wk Range: 2.786 - 6.990 1-Yr Rtn: +55.27%

Stock Chart for NNF1

No chart data available.
  • NNF1:GR 4.658
  • 1D
  • 1M
  • 1Y
4.596
Interactive NNF1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NNF1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3410
Est. PEG Ratio -
Market Cap (M EUR) 1,797.29
Shares Outstanding (M) 385.85
30 Day Average Volume 7,405
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NNF1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NNF1

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.

Alfred E MannChairman/CEOHakan S EdstromPresident/COO
Matthew J Pfeffer "Matt"VP/CFO/Investor RelationsDavid B ThomsonVP/Secy/General Counsel
More Company Profile & Key Executives for NNF1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil